Does eribulin mesylate provide benefits for HER2+?

Save as Favorite
Sign in to receive recommendations (Learn more)
Question from LAN: Does eribulin mesylate (brand name: Halaven) provide any special benefits to patients with HER2-positive breast cancer?
Answers - Eric Winer, M.D. We don't know if eribulin is any more or less effective in HER2-positive breast cancer than in other types of breast cancer. To date we have no data on the combination of eribulin and Herceptin.

The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.

Editor's Note: This conference took place in December 2010.

The materials presented in these conferences do not necessarily reflect the views of A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.

Fallappeal2016 popupad 300x125 1
Back to Top